Individuals Coming Off Slimming Jabs Regain Pounds Four Times Faster Than People Using Diet and Exercise

Fresh analysis indicates that patients who come off popular weight-loss injections like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who end traditional lifestyle regimens.

Research printed in a prominent health publication shows that while obese people can lose about a fifth of their body weight while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals purchasing these medications should be informed of the potential of fast rebound weight gain when the medication is stopped," warns researcher Dr. Susan Jebb.

Such speed of recovery implies a return to pre-treatment weight in about 18 months.

Analyzing Therapies

The study, which reviewed dozens of trials involving over 9,000 of participants, compared the results of the injectable medications with other pills.

Scientists note that individuals who lose weight through diet and exercise generally experience a more gradual weight regain—around 0.1 kg a month—after stopping.

Understanding the Rapid Regain

Experts suggest the mode of action of the jabs accounts for the accelerated rebound.

The injections imitate a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.

"Long-term administration of the hormone levels several times higher than normal may cause the system to produce less of its endogenous GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement means hunger is uncontrolled, making excessive eating much more probable."

An Ongoing Issue?

Medical guidelines advise the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.

Many experts say that, given the significant potential of relapse, the therapy might need to be ongoing.

This perspective is reinforced by pharmaceutical companies, who say that the results "emphasize the persistent character of excess weight," similar to managing conditions like hypertension.

User Accounts

People who have discontinued the medication report a sudden resurgence of cravings.

"It was like a switch that goes on and you become ravenous," said one woman.

The struggle is compounded if users have not adopted permanent dietary or behavioural changes during therapy.

Growing Adoption

Recent estimates suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with desire remaining high.

• Use is more common among females than men.
• The 40s and 50s demographic shows the highest level of interest.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

Finally, researchers emphasize that while these medications are powerful agents for shedding pounds, they are not a permanent solution and maintained weight loss relies on combined lifestyle changes.